Advances in the laboratory diagnosis of Mycobacterium tuberculosis

Annals of African Medicine

Volumn 7, Issue 2, 2008, Pages 57-61

  Ani, A ^a  

^a UNIVERSITY OF JOS   (Nigeria)

Author keywords

challenges; laboratory investigation; multidrug resistance; Mycobacterium tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

AIDS RELATED COMPLEX; DIAGNOSIS, MEASUREMENT AND ANALYSIS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; REVIEW; STANDARD; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 58949085409     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.55680     Document Type: Review

References (34)

1. Nunn P, Harries A, Faussett-Godfery P, Gupta R, Maher D, Raviglione M. The research agenda for improving health policy, systems performance and service delivery for tuberculosis control; a WHO perspective. Bull World Health Organ. 2002;80:471-476. (Pubitemid 34632825)
2. Centres for disease control and prevention. Initial therapy for tuberculosis in the era of the advisory counsil for the elimination of tuberculosis. MMWR Morb Mortal Wkly Rep. 2003;42:1-8.
3. Strategic direction for research. World Health Organisation, Geneva, 2002.
4. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142:725-735.
5. Katoch VM. Infections due to non tuberculous mycobacteria (NTM). Indian J Med Res. 2004;120:290-304. (Pubitemid 39504469)
6. Kent PT, Kubica GP. Public health mycobacteriology. A guide to the level III laboratory. US Department of Health and Human Services. PHS CDC AG 1985; 30333.
7. Lawson L, Yassin MA, Ramsay A, et al. Microbiological validation of smear microscopy after sputum digestion with bleach; a step closer to a one-stop diagnosis of pulmonary tuberculosis. Tuberculosis (Edinb). 2006;86:34-40. (Pubitemid 41797657)
8. Sidiqi SH, Libonati JP, Middlebrook G. Evaluation of rapid radiometric method for drug susceptibility testing of mycobacterium tuberculosis. J Clin Microbiol. 1981;13:908-912. (Pubitemid 11094080)
9. Heifets LB. Drug susceptibility tests in the management of chemotherapy of tuberculosis. In: Heifets LB (ed). Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, 1991; 89-1121.
10. Hanna BA, Ebrahimzadeh A, Elliott LB, et al. Multicentre evaluation of the BACTEC MGIT 960 System for recovery of mycobacteria. J Clin Microbiol. 1999;37:748-752. (Pubitemid 29091296)
11. Tortoli E, Mattei R, Savarino A, Bartolini I, Beer J. Comparison of mycobacterial tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickson) and MB/BacT (Organon Teknika) systems. Diagn Microbiol Infect Dis. 2000;38:83-86.
12. Oberoi A, Kaur H. Comparison of rapid colorimetric method with conventional method in the isolation of mycobacterium tuberculosis. Int J Med Sci. 2004;22:44-46. (Pubitemid 38292465)
13. Claudio P, Armando O, Luka B, Claudio S. Current perspectives on drug susceptibility testing of mycobcterium tuberculosis complex: The automated non radiometric system. J Clin Microbiol. 2006;44:20-26.
14. Diaz-Infantes MS, Ruiz-Serrano MJ, Martinez-Sanchez L, Ortega A, Bonza E. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of mycobcterial tuberculosis. J Clin Microbiol. 2000;38:1988-1989. (Pubitemid 30253952)
15. Yew WW, Tong SC, Lui KS, Leung KF, Chau CH, Wang EP. Comparison of MB/BacT system and agar proportion method in drug susceptibility testing of mycobactereium tuberculosis. Diagn Microbact Infect. 2001;39:229-232. (Pubitemid 32524260)
16. Huang T, Tu H, Lee SS, Huang W, Liu Y. Antimicrobial susceptibility testing of mycobacterium tuberculosis to first line drugs: comparison of the MGIT 960 and BACTEC 460 systems. Ann Clin Lab Sci. 2002;32:142-147. (Pubitemid 34450515)
17. Adjers-Koskelat K, Katila MI. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and MGIT 960 system provides rapid and reliable verification of multi-drug resistant tuberculosis. J Clin Microbiol. 2003;41:1235-1239.
18. Eisenach KD, Crawford JT, Bates JH. Repetitive DNA sequences as probes for mycobacterium tuberculosis. J Clin Microbiol. 1988;26:2240.
19. Wiid IJF, Werely C, Beyers N, Donald P, van Helden PD. Oligonucleotide (GTG) as a marker for mycobacterium tuberculosis strain identification. J Clin Microbiol. 1994;32:1318-1321. (Pubitemid 24132566)
20. Van Embden JDA, Schuls IM, van Sooligen D. Applications in epidemiological studies In: Thoen CO, Steele JH (eds). Molecular techniques. Iowa State University Press, Ames, Iowa, 1995; 15-27.
21. Kamerbeek J, Schouls L, Kolk A, et al. Rapid detection and simultaneous strain differentiation of mycobacterium tuberculosis. J Clin Microbiol. 1997;35:907-914. (Pubitemid 27146535)
22. Yang Z. Molecular epidemiology of tuberculosis. Front Biosci. 2003;8d:440-450.
23. Eisenach KD, Cave MD, Bates JH, Crawford JT. Polymerase chain reaction amplification of a repetitive DNA sequence specific for mycobacterium tuberculosis. J Infect Dis. 1990;161:977-981. (Pubitemid 20148335)
24. Eisenach KD, Sifford MD, Cave MD, Bates JH, Crawford JT. Detection of M. tuberculosis in sputum sample using polymerase chain reaction. Am Rev Respir Dis. 1991;144:1160-1163.
25. Van Sooligen D, Hermans PWM, de Haas PEW, Soll DR, van Embden JDA. The occurrence and stability of insertion sequences in mycobacterium tuberculosis complex strains; evaluation of IS dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2578-2586.
26. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction fragment length polymorphisms. N Engl J Med. 1992;326:231-235.
27. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardised methodology. J Clin Microbiol. 1993;31:406-409. (Pubitemid 23028649)
28. Supply P, Edith M, Sarah L, Veronica V, Brigitte G, Camille L. Variable human-like region in the mycobacterium tuberculosis genome. Mol Microbiol. 2000;36:762-771. (Pubitemid 30258858)
29. Heym B, Honore N, Truffot-Pernot C, et al. Implication of multi drug resistance for the future short course chemotherapy of tuberculosis: a molecular study. Lancet. 1994;344:293-298. (Pubitemid 24230296)
30. Takiff HE, Salazar L, Guerrero C, et al. Clonning and nucleotide sequencing of mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother. 1994;38:773-780. (Pubitemid 24114017)
31. Cooksey RC, Morlook GP, McQueen A, Gleeckman SE, Crawford JT. Characterisation of streptomycin resistance mechanisms among mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother. 1996;40:1186-1188. (Pubitemid 26136032)
32. Torres MJ, Criado A, Palomares JC, Aznat J. Use of real time PCR and fluorometry for rapid detection of rifampicin and isoniazid resistance associated mutations in mycobacterium tuberculosis. J Clin Microbiol. 2000;38:3194-3199.
33. Gingras TR, Ghandour G, Wang E, et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic mycobacterium arrays. Genome Res. 1990;8:435-448.
34. Troesch A, Nguyen H, Miyada CC, et al. Mycobacterium species identification and rifampicin resistance testing with high density DNA probe arrays. J Clin Microbiol. 1999;37:49-55. (Pubitemid 29004179)